• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DrugRepV:针对流行和大流行病毒的再利用药物和化学品摘要。

DrugRepV: a compendium of repurposed drugs and chemicals targeting epidemic and pandemic viruses.

机构信息

Virology Unit and Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39A, Chandigarh-160036, India.

Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India.

出版信息

Brief Bioinform. 2021 Mar 22;22(2):1076-1084. doi: 10.1093/bib/bbaa421.

DOI:10.1093/bib/bbaa421
PMID:33480398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7929368/
Abstract

Viruses are responsible for causing various epidemics and pandemics with a high mortality rate e.g. ongoing SARS-CoronaVirus-2 crisis. The discovery of novel antivirals remains a challenge but drug repurposing is emerging as a potential solution to develop antivirals in a cost-effective manner. In this regard, we collated the information of repurposed drugs tested for antiviral activity from literature and presented it in the form of a user-friendly web server named 'DrugRepV'. The database contains 8485 entries (3448 unique) with biological, chemical, clinical and structural information of 23 viruses responsible to cause epidemics/pandemics. The database harbors browse and search options to explore the repurposed drug entries. The data can be explored by some important fields like drugs, viruses, drug targets, clinical trials, assays, etc. For summarizing the data, we provide overall statistics of the repurposed candidates. To make the database more informative, it is hyperlinked to various external repositories like DrugBank, PubChem, NCBI-Taxonomy, Clinicaltrials.gov, World Health Organization and many more. 'DrugRepV' database (https://bioinfo.imtech.res.in/manojk/drugrepv/) would be highly useful to the research community working to develop antivirals.

摘要

病毒是导致各种高死亡率的传染病和大流行的罪魁祸首,例如目前正在发生的严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)危机。新型抗病毒药物的发现仍然是一个挑战,但药物再利用正成为一种有潜力的解决方案,可以以具有成本效益的方式开发抗病毒药物。在这方面,我们从文献中整理了用于抗病毒活性测试的再利用药物的信息,并以名为“DrugRepV”的用户友好型网络服务器的形式呈现。该数据库包含 8485 条条目(3448 个独特条目),包含 23 种导致传染病/大流行的病毒的生物学、化学、临床和结构信息。该数据库提供了浏览和搜索选项,可用于探索再利用药物条目。可以通过药物、病毒、药物靶点、临床试验、测定法等重要字段来探索数据。为了总结数据,我们提供了再利用候选药物的总体统计信息。为了使数据库更具信息量,它与 DrugBank、PubChem、NCBI-Taxonomy、Clinicaltrials.gov、世界卫生组织等各种外部存储库建立了超链接。“DrugRepV”数据库(https://bioinfo.imtech.res.in/manojk/drugrepv/)将对致力于开发抗病毒药物的研究界非常有用。

相似文献

1
DrugRepV: a compendium of repurposed drugs and chemicals targeting epidemic and pandemic viruses.DrugRepV:针对流行和大流行病毒的再利用药物和化学品摘要。
Brief Bioinform. 2021 Mar 22;22(2):1076-1084. doi: 10.1093/bib/bbaa421.
2
Computational identification of repurposed drugs against viruses causing epidemics and pandemics via drug-target network analysis.通过药物-靶点网络分析发现针对引发流行病和大流行病的病毒的再利用药物。
Comput Biol Med. 2021 Sep;136:104677. doi: 10.1016/j.compbiomed.2021.104677. Epub 2021 Jul 23.
3
Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning.利用人工智能和机器学习预测冠状病毒的药物新用途
Comput Struct Biotechnol J. 2021;19:3133-3148. doi: 10.1016/j.csbj.2021.05.037. Epub 2021 May 24.
4
Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data.重新利用药物对抗 SARS-CoV-2 的主蛋白酶:基于机制的见解,得到了现有实验室和临床数据的支持。
Mol Omics. 2020 Oct 1;16(5):474-491. doi: 10.1039/d0mo00057d. Epub 2020 Jul 22.
5
Integrating Proteomics for Facilitating Drug Identification and Repurposing During an Emerging Virus Pandemic.整合蛋白质组学以促进新兴病毒大流行期间的药物鉴定和再利用。
ACS Infect Dis. 2021 Jun 11;7(6):1303-1316. doi: 10.1021/acsinfecdis.0c00579. Epub 2020 Dec 15.
6
Clinical Trials of Repurposed Antivirals for SARS-CoV-2.抗 SARS-CoV-2 再利用抗病毒药物的临床试验。
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.01101-20.
7
Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.药物重新利用研究确定了潜在的新冠病毒抗病毒药物。
JAMA. 2020 Sep 8;324(10):928. doi: 10.1001/jama.2020.15948.
8
Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods.通过计算方法鉴定一种重新利用的药物作为人类冠状病毒SARS-CoV-2刺突蛋白的抑制剂。
J Biosci. 2020;45(1). doi: 10.1007/s12038-020-00102-w.
9
Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL targeting repurposed drug candidates.SARS-CoV2 的地理多样性演变和针对复制酶 3CL 的计算机分析,以寻找可再利用药物的候选物。
J Transl Med. 2020 Jul 9;18(1):278. doi: 10.1186/s12967-020-02448-z.
10
Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine.环孢素同时抑制 SARS-CoV-2 的进入途径。
ACS Chem Neurosci. 2021 Mar 3;12(5):930-944. doi: 10.1021/acschemneuro.1c00019. Epub 2021 Feb 19.

引用本文的文献

1
i-DENV: development of QSAR based regression models for predicting inhibitors targeting non-structural (NS) proteins of dengue virus.登革病毒I型:基于定量构效关系的回归模型开发,用于预测靶向登革病毒非结构(NS)蛋白的抑制剂
Front Pharmacol. 2025 Jun 26;16:1605722. doi: 10.3389/fphar.2025.1605722. eCollection 2025.
2
Anti-Dengue: A Machine Learning-Assisted Prediction of Small Molecule Antivirals against Dengue Virus and Implications in Drug Repurposing.抗登革热:一种基于机器学习的小分子抗登革病毒药物预测及其在药物再利用方面的意义。
Viruses. 2023 Dec 27;16(1):45. doi: 10.3390/v16010045.
3
A review of SARS-CoV-2 drug repurposing: databases and machine learning models.新型冠状病毒2型药物重新利用综述:数据库与机器学习模型
Front Pharmacol. 2023 Aug 4;14:1182465. doi: 10.3389/fphar.2023.1182465. eCollection 2023.
4
Artificial Intelligence, Machine Learning, and Big Data for Ebola Virus Drug Discovery.用于埃博拉病毒药物研发的人工智能、机器学习和大数据
Pharmaceuticals (Basel). 2023 Feb 21;16(3):332. doi: 10.3390/ph16030332.
5
In Silico Identification of Anti-SARS-CoV-2 Medicinal Plants Using Cheminformatics and Machine Learning.基于 cheminformatics 和机器学习的抗 SARS-CoV-2 药用植物的计算机筛选。
Molecules. 2022 Dec 26;28(1):208. doi: 10.3390/molecules28010208.
6
In silico identification of potential inhibitors of vital monkeypox virus proteins from FDA approved drugs.从 FDA 批准的药物中鉴定潜在的关键猴痘病毒蛋白抑制剂的计算机筛选。
Mol Divers. 2023 Oct;27(5):2169-2184. doi: 10.1007/s11030-022-10550-1. Epub 2022 Nov 4.
7
Anti-Ebola: an initiative to predict Ebola virus inhibitors through machine learning.抗埃博拉:通过机器学习预测埃博拉病毒抑制剂的研究计划。
Mol Divers. 2022 Jun;26(3):1635-1644. doi: 10.1007/s11030-021-10291-7. Epub 2021 Aug 6.
8
Computational identification of repurposed drugs against viruses causing epidemics and pandemics via drug-target network analysis.通过药物-靶点网络分析发现针对引发流行病和大流行病的病毒的再利用药物。
Comput Biol Med. 2021 Sep;136:104677. doi: 10.1016/j.compbiomed.2021.104677. Epub 2021 Jul 23.
9
NOD: a web server to predict New use of Old Drugs to facilitate drug repurposing.NOD:一个用于预测旧药新用途的网络服务器,以促进药物再利用。
Sci Rep. 2021 Jun 29;11(1):13540. doi: 10.1038/s41598-021-92903-8.
10
Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning.利用人工智能和机器学习预测冠状病毒的药物新用途
Comput Struct Biotechnol J. 2021;19:3133-3148. doi: 10.1016/j.csbj.2021.05.037. Epub 2021 May 24.